• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hemorrhage, Subarachnoid (1893)
Event Date 07/22/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that patient had stroke following lvad implant on (b)(6)2020 in the left cerebral hemisphere area.Patient presented at that time with aphasia.Additional information states that patient had an ischemic stroke, the anticoagulation was held peri/post operatively.Ct scan was performed.Patient had aphasia post-extubating.Resumption delayed due to concern for hemorrhagic conversion.Anticoagulation resumed without incident on post operative day 4.A serial head ct and neuro exams stable from time of incident to time of resumption.
 
Event Description
It was later reported that the patient also had a subarachnoid hemorrhage.The patient was immediately post-implant at the time of the initial cerebrovascular accident (cva).The patient had a head computed tomography (ct) scan.The patient was aphasic after extubation following surgical implant.The patient underwent serial ct scans and was treated with conservative anticoagulation.There was no surgical intervention.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct relationship between heartmate 3 lvas, serial number (b)(6), and the reported events could not be conclusively established through this evaluation.The patient remained ongoing on heartmate 3 lvas, serial number (b)(6) until they ultimately expired on (b)(6) 2020 (addressed under mfr # 2916596-2020-05264).No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped to the customer on (b)(6) 2020.The heartmate 3 lvas ifu lists stroke, bleeding and other neurological events (not stroke-related) as adverse events that may be associated with the use of heartmate 3 left ventricular assist system.Additionally, section 6 lists neurologic dysfunction as a potential late postimplant complication that may be associated with the use of heartmate 3 left ventricular assist system.This section also contains information regarding the recommended anticoagulation therapy and inr range.No further information was provided.The manufacturer is closing this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key10750604
MDR Text Key213657697
Report Number2916596-2020-05273
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/12/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number7550516
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/19/2020
Initial Date FDA Received10/28/2020
Supplement Dates Manufacturer Received11/17/2020
Supplement Dates FDA Received11/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age72 YR
Patient Weight97
-
-